A phase I/II study of epertinib plus trastuzumab with or without chemotherapy in patients with HER2-positive metastatic breast cancer

por Macpherson, Iain R., Spiliopoulou, Pavlina, Rafii, Saeed, Saggese, Matilde, Baird, Richard D., Garcia-Corbacho, Javier, Italiano, Antoine, Bonneterre, Jacques, Campone, Mario, Cresti, Nicola, Posner, John, Takeda, Yousuke, Arimura, Akinori, Spicer, James
Publicado 2019